Leaflet LERCARIL 20mg / 20mg film-coated tablets

Indicated for: hypertension

Route of administration: oral

Substance: enalapril + lercanidipine (ACE inhibitor + calcium channel blocker)

ATC: C09BB02 (Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers)

Precautions:
Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

The combination of Enalapril + lercanidipine is used for the treatment of essential hypertension in patients requiring combination therapy. It combines an angiotensin-converting enzyme (ACE) inhibitor (enalapril) with a calcium channel blocker (lercanidipine) to lower blood pressure.

The medication is taken orally, usually once daily, and is effective in reducing the risk of cardiovascular complications such as stroke or heart attack.

Side effects may include dizziness, headache, peripheral edema, dry cough, or nausea. It is important to monitor blood pressure and kidney function during treatment.

Consult your doctor to discuss the benefits and risks of treatment with this combination. Follow the prescribed dosage and adhere to all medical recommendations.

General data about LERCARIL 20mg / 20mg

  • Substance: enalapril + lercanidipine
  • Date of latest medicines list: 01-06-2026
  • Product code: W61013003
  • Concentration: 20mg / 20mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 28
  • Product type: Original
  • Price: 33.50 RON
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. - ITALIA
  • Holder: RECORDATI IRELAND LIMITED - IRLANDA
  • Number: 11505/2019/03
  • Shelf life: 2 years

Concentrations available for enalapril + lercanidipine

  • 10mg/10mg
  • 20mg/10mg
  • 20mg/20mg

Compensation lists for LERCARIL 20mg / 20mg Recordati

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

33.50 RON

16.75 RON

16.75 RON